Get the Stockscreener App
0.7053
3.54%
-0.0153
After Hours:
.72
0.0147
+2.08%
Imunon Inc stock is traded at $0.7053, with a volume of 92,069.
It is down -3.54% in the last 24 hours and down -29.47% over the past month.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.
See More
Previous Close:
$0.7206
Open:
$0.7381
24h Volume:
92,069
Relative Volume:
0.29
Market Cap:
$10.12M
Revenue:
$500.00K
Net Income/Loss:
$-19.52M
P/E Ratio:
-0.1871
EPS:
-3.77
Net Cash Flow:
$-19.47M
1W Performance:
-16.12%
1M Performance:
-29.47%
6M Performance:
-50.35%
1Y Performance:
-27.21%
1-Day Range:
$0.6806
$0.7381
1-Week Range:
$0.6669
$0.84
52-Week Range:
$0.48
$3.65
Imunon Inc Stock (IMNN) Company Profile
Name
Imunon Inc
Sector
Industry
Phone
(609) 896-9100
Address
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| IMNN | 0.7053 | 10.12M | 500.00K | -19.52M | -19.47M | -3.77 |
| VRTX | 467.12 | 119.83B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.38 | 83.28B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.35 | 33.74B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.38B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.83 | 24.08B | 3.30B | -501.07M | 1.03B | 11.54 |
Imunon Inc Stock (IMNN) Latest News
FY2024 EPS Estimates for Imunon Boosted by Zacks Small Cap - Defense World
Analysts Set Expectations for Imunon Q1 Earnings - Defense World
Imunon, Inc. (NASDAQ:IMNN) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Imunon reveals promising ovarian cancer study results - Investing.com India
Earnings call: Imunon reveals promising ovarian cancer study results By Investing.com - Investing.com UK
Imunon Inc (IMNN) Q3 2024 Earnings Call Highlights: Promising Clinical Advances Amid Financial ... - Yahoo Finance
Imunon, Inc. Reports Q3 2024 Earnings and Progress - TipRanks
Imunon Inc (IMNN) Quarterly 10-Q Report - Quartzy
Imunon presents data from Phase 2 OVATION 2 clinical trial - TipRanks
IMUNON Presents Positive Data from Phase 2 OVATION 2 - GlobeNewswire
IMUNON's Cancer Drug Shows 35% Survival Boost in Phase 2 Ovarian Cancer Trial | IMNN Stock News - StockTitan
Imunon sees cash runway into 3Q25 - TipRanks
IMUNON Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire
IMUNON INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
Imunon (IMNN) to Release Quarterly Earnings on Thursday - MarketBeat
IMUNON to Hold Third Quarter 2024 Financial Results and - GlobeNewswire
IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024 - Yahoo Finance
IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of - GlobeNewswire
IMUNON, Inc. to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting - Marketscreener.com
Imunon’s stock rockets after ovarian cancer treatment’s positive trial results - MSN
Imunon reports inducement grant under NASDAQ listing rule - Yahoo Finance
Ex-Allstate Atty Named Biotech Co.'s General Counsel - Law360
Imunon Welcomes Susan Eylward as General Counsel, Strengthens Leadership Team - TipRanks
IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
Imunon, Inc. Appoints Susan Eylward as General Counsel and Corporate Secretary - Marketscreener.com
Imunon (NASDAQ:IMNN) Upgraded by EF Hutton Acquisition Co. I to “Strong-Buy” - Defense World
Imunon (NASDAQ:IMNN) Upgraded to "Strong-Buy" at EF Hutton Acquisition Co. I - MarketBeat
EF Hutton sets stock target on Imunon, initiates with buy rating - Investing.com Canada
Ratio Review: Analyzing Imunon Inc (IMNN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Imunon Inc (IMNN) may enjoy gains as insiders got busy in the recent days - Knox Daily
Imunon (NASDAQ:IMNN) Stock, Analyst Ratings, Price Targets, Forecasts - Benzinga
You might want to take a look at Imunon Inc (IMNN) now - SETE News
A review of IMNN’s current quarter earnings predictions - US Post News
Imunon (NASDAQ:IMNN) Shares Up 5.6% - Defense World
IMNN (Imunon Inc) may reap gains as insiders became active recently - Knox Daily
UPDATEIMUNON’s Ovarian Cancer R&D Day to Feature - GlobeNewswire
IMNNImunon, Inc. Latest Stock News & Market Updates - StockTitan
IMUNON’s Ovarian Cancer R&D Day to Feature Presentations - GlobeNewswire
IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management - StockTitan
Imunon Inc. resumes ATM equity offering - Investing.com
Ratios Uncovered: Breaking Down Imunon Inc (IMNN)’s Trailing Twelve Months Metrics - The Dwinnex
Imunon Inc’s latest rating changes from various analysts - Knox Daily
The Attractiveness of Investing In Imunon Inc (IMNN) is Growing - Knox Daily
IMUNON to Host R&D Day on September 18th - GlobeNewswire
A significant driver of top-line growth: Imunon Inc (IMNN) - SETE News
Celsion Corporation : Celsion Announces Official ThermoDox® HEAT Study Results to be presented at the International Liver Cancer Association (ILCA) 2013 Annual Conference in Washington, D.C. on September 14, 2013 - Marketscreener.com
Imunon Inc [IMNN] Investment Guide: What You Need to Know - Knox Daily
Imunon Inc (IMNN) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Market Watch: Imunon Inc (IMNN)’s Noteworthy Gain, Closing at 1.14 - The Dwinnex
Q3 2024 EPS Estimates for Imunon, Inc. (NASDAQ:IMNN) Increased by Analyst - Defense World
Q3 2024 Earnings Estimate for Imunon, Inc. (NASDAQ:IMNN) Issued By Brookline Capital Management - Defense World
Imunon Inc Stock (IMNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Imunon Inc Stock (IMNN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Tardugno Michael H | Executive Chairman of Board |
Aug 15 '24 |
Buy |
1.03 |
25,000 |
25,750 |
353,346 |
4.27%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):